One-Chip Biotechnology is mainly engaged in developing molecular diagnostic products such as semiconductor gene sequencer and microfluidic nucleic acid detection systems. The company focuses on disruptive technological innovation, has applied for more than 150 intellectual property rights, completed a cumulative financing of more than 300 million yuan.

Having core research and development team of nearly 100 people, OneChip has established pioneering R & D capability in biochip technology, genetic test reagent and instrumentation. OneChip has built three GMP manufacturing centers for mass-production and CDMO services.

OneChip won many awards including the Global Medical Technology Innovation Award 2024. We strive to provide innovative products and professional solutions for healthcare and precision medicine, animal, agriculture, and enviromental industries.